Back to Search Results
Punit Agrawal
Schedule an appointment (855) 255-0550
Insurances We Accept
Punit Agrawal, DO, is a neurologist and clinical assistant professor of neurology at The Ohio State University Wexner Medical Center. His clinical focus is the treatment of Parkinson’s disease, tremor, dystonia and other movement disorders. Dr. Agrawal has specific clinical interest in the use of deep brain stimulation therapy for the treatment of approved movement disorders including Parkinson’s disease, tremor and primary dystonia. He also is trained and practices treatment of focal dystonia with botulinum toxin therapy. He is involved in clinical research trials for movement disorders and also neuromodulation.

Dr. Agrawal earned his doctor of osteopathic medicine at the University Of New England College Of Osteopathic Medicine in Biddeford, Maine. He completed both his residency in neurology and fellowship in movement disorders at Ohio State. He joined the Neurology faculty at Ohio State in July 2007.

Highlights

  • Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2015

Medical Degree

  • D.O.
    Univ of New England College of Oste
    6/30/2002

Residency

  • Neurology
    Ohio State University Wexner Medical Ctr
    7/1/2003 - 6/30/2006

Specialties and conditions I treat

  • Neurology
  • Dystonia
  • Deep Brain Stimulation
  • Myoclonus
  • Spinal Cord Stimulation
  • Movement Disorders
  • Tremor
  • Parkinson's Disease

My videos

Locations where I practice

Please note: Not all physicians schedule patients at each listed location. Please call the “Schedule an appointment” number shown above for scheduling assistance.

More about my work

My background

Fellowship

  • Movement Disorders
    Ohio State University Wexner Medical Ctr
    7/1/2006 - 6/30/2007

Board Certification

American Board of Psychiatry & Neurology (Subspecialty: Neurology)
9/11/2009

My Department

Neurology

Industry Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 03/25/2016, Dr. Agrawal has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.

  • Teva Pharmaceuticals